Yüklüyor......
Rebound Hypercalcemia After Denosumab Therapy in a Child With Cherubism
Background: Cherubism, caused by autosomal dominant mutations in the SH3BP2 gene, is characterized by increased bone resorption with development of bilateral fibro-osseous lesions limited to the maxilla and mandible. The SH3BP2 gene is thought to be involved in osteoclastogenesis. Affected children,...
Kaydedildi:
| Yayımlandı: | J Endocr Soc |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089366/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.442 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|